A European, Randomised, Double-blind, Active Comparator Controlled, Cross-over, Efficacy and Safety Study of a New 10% Ready To-use Liquid Human Intravenous Immunoglobulin (I10E) Versus Kiovig in Patients With Multifocal Motor Neuropathy

Trial Profile

A European, Randomised, Double-blind, Active Comparator Controlled, Cross-over, Efficacy and Safety Study of a New 10% Ready To-use Liquid Human Intravenous Immunoglobulin (I10E) Versus Kiovig in Patients With Multifocal Motor Neuropathy

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Dec 2016

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Multifocal motor neuropathy
  • Focus Registrational; Therapeutic Use
  • Acronyms LIME
  • Sponsors LFB Biotechnologies
  • Most Recent Events

    • 07 Aug 2016 This trial is completed in spain.
    • 18 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 11 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top